Anti-Inflammatory gel may shield cancer patients from radiation burns

NCT ID NCT06905561

First seen Apr 11, 2026 · Last updated Jun 13, 2026 · Updated 9 times

Summary

This study tests whether a gel containing diclofenac (a common anti-inflammatory drug) can prevent severe skin irritation caused by radiation therapy. About 156 adults with head/neck or breast cancer who are starting radiation will apply the gel to the treated skin area. The goal is to see if the gel reduces the chance of developing painful skin burns, which can interrupt cancer treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Second Affiliated Hospital of Hainan Medical University

    RECRUITING

    Haikou, Hainan, 570311, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.